Nurse Practitioner · Lafayette, LA
NPI
1144325887
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2390 West Congress
Lafayette, LA, 70596
Phone (337) 261-6356
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,061
120 services
Medicare patients, 2024
50
Average age 59
Drug cost, 2024
$3.6M
1,825 prescriptions
Company payments, 2025
$198
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mandy C Rainey was code 99214 (office e&m - established), 61 times for 34 patients. In total Mandy C Rainey billed 120 services in 8 codes, and Medicare paid $5,061.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 61 | 34 | $44.90 | $2,739 |
| 99213 Office E&M - Established | Facility | 23 | 13 | $36.74 | $845 |
By year: 2022 $7,819 for 144 services; 2023 $6,622 for 154 services; 2024 $5,061 for 120 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mandy C Rainey prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 317 prescriptions and refills. In total Mandy C Rainey wrote 1,825 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 317 | 317 | 49 | $1.3M |
| Tivicay Dolutegravir Sodium | 209 | 209 | 33 | $503K |
| Descovy Emtricitabine/Tenofov Alafenam | 129 | 137 | 18 | $296K |
| Ritonavir Generic | 108 | 124 | 15 | $10K |
| Abacavir Abacavir Sulfate | 77 | 87 | 11 | $14K |
| Darunavir Generic | 73 | 79 | 11 | $78K |
| Vemlidy Tenofovir Alafenamide | 71 | 71 | 13 | $105K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 71 | 71 | Under 11 | $253K |
| Atovaquone Generic | 62 | 62 | 11 | $32K |
| Pifeltro Doravirine | 59 | 59 | Under 11 | $101K |
| Atorvastatin Calcium Generic | 52 | 75 | 14 | $195 |
| Alendronate Sodium Generic | 48 | 62 | Under 11 | $231 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 43 | 43 | Under 11 | $201K |
| Prezcobix Darunavir/Cobicistat | 31 | 31 | Under 11 | $77K |
| Pravastatin Sodium Generic | 29 | 37 | Under 11 | $292 |
Brand drugs: 1,027 claims; generic drugs: 798 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mandy C Rainey $198 ($198 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $102.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.